0001209191-18-054919.txt : 20181015
0001209191-18-054919.hdr.sgml : 20181015
20181015092408
ACCESSION NUMBER: 0001209191-18-054919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181012
FILED AS OF DATE: 20181015
DATE AS OF CHANGE: 20181015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAUWENBERGH GEERT
CENTRAL INDEX KEY: 0001285648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 181121484
MAIL ADDRESS:
STREET 1: 1 STULTS DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-12
0
0001533040
RXi Pharmaceuticals Corp
RXII
0001285648
CAUWENBERGH GEERT
C/O RXI PHARMACEUTICALS CORPORATION
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
1
1
0
0
President & CEO
Common stock, $0.0001 par value
2018-10-12
4
A
0
17230
0.4699
A
126075
D
Common stock, $0.0001 par value
450
I
By spouse
As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on October 12, 2018, the reporting person received a total of 17,230 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date.
Caitlin Kontulis, attorney-in-fact
2018-10-15